Pharmacovigilance Services in Sweden: Supporting Drug Safety Across the Product Lifecycle

 

Pharmacovigilance plays a critical role in protecting patients and maintaining the safety profile of medicines throughout their development and commercial lifecycle. From adverse event processing during clinical trials to post-marketing safety surveillance, effective pharmacovigilance requires structured processes, medical expertise, accurate data management, and timely reporting.

For organizations conducting clinical research or commercializing products in Sweden, Pharmacovigilance Services in Sweden can provide specialized support for managing safety information and meeting applicable regulatory requirements.

CurexBio offers end-to-end pharmacovigilance services covering clinical development through post-marketing surveillance, supported by experienced safety professionals and technology-driven safety systems.

What Are Pharmacovigilance Services?

Pharmacovigilance is the science and activities involved in detecting, assessing, understanding, and preventing adverse effects and other drug-related problems.

Pharmacovigilance activities can include:

• Adverse event and serious adverse event management
• Individual Case Safety Report (ICSR) processing
• Medical review and causality assessment
• Safety data management
• Signal detection
• Literature monitoring
• Aggregate safety reporting
• Risk management
• Regulatory safety submissions

These activities help organizations continuously evaluate the safety and benefit-risk profile of their products.

Pharmacovigilance Services in Sweden

Sponsors conducting clinical trials or managing marketed products in Sweden may require ongoing safety monitoring and regulatory reporting throughout the product lifecycle.

CurexBio provides flexible pharmacovigilance support designed to cover safety requirements from first-in-human studies through post-marketing surveillance.

Adverse Event & ICSR Management

Accurate handling of safety cases is a fundamental part of pharmacovigilance.

CurexBio supports:

• Adverse Event (AE) processing
• Serious Adverse Event (SAE) management
• ICSR identification and processing
• Case intake and triage
• Data entry
• Medical coding
• Quality control
• Safety database reconciliation

The company also describes 24/7 case intake mechanisms and the use of standardized medical dictionaries such as MedDRA and WHO Drug.

Medical Review & Causality Assessment

Safety cases often require clinical interpretation to determine the relationship between an adverse event and a medicinal product.

Medical review activities may include:

• Clinical assessment of individual cases
• Causality assessment
• Review of medical history
• Evaluation of adverse events
• Medical interpretation for regulatory reporting

CurexBio provides medical review and causality assessment through qualified safety professionals.

Safety Reporting

Timely safety reporting is an important component of pharmacovigilance operations.

Support can include preparation of:

• SUSARs
• DSURs
• PSURs
• PBRERs
• PADER/PAER
• Other periodic and expedited safety reports

CurexBio provides support for expedited and aggregate reporting as part of its pharmacovigilance services.

Signal Detection & Safety Data Evaluation

Continuous evaluation of safety information can help identify potential changes in a product's safety profile.

Signal management may involve:

• Safety data review
• Signal detection
• Signal validation
• Trend analysis
• Medical assessment
• Risk evaluation
• Ongoing safety monitoring

CurexBio supports signal detection and safety data evaluation as part of its proactive pharmacovigilance approach.

Risk Management Planning

Risk management focuses on identifying and addressing important or potential risks associated with a medicinal product.

Services may include:

• Benefit-risk assessment
• Risk Management Plans (RMPs)
• Risk identification
• Risk evaluation
• Risk minimization strategies
• Ongoing review of safety information

CurexBio provides risk management planning and benefit-risk analysis support.

Literature Monitoring

Scientific and medical literature can provide additional safety information about medicinal products.

Literature monitoring may help identify:

• Newly reported adverse events
• Emerging safety concerns
• Published clinical safety information
• Relevant product-related safety data

CurexBio includes global literature search and review within its pharmacovigilance services.

Safety Database Management

Safety databases are central to managing and tracking pharmacovigilance information.

CurexBio supports safety database configuration and oversight, including platforms such as Oracle Argus, along with safety data management and system support.

The company also highlights validated safety systems, data integrity, and electronic safety data transmission requirements in its pharmacovigilance operations.

EudraVigilance Support

For products requiring European safety reporting, appropriate handling of safety information and electronic reporting is an important consideration.

CurexBio provides EudraVigilance assistance as part of its safety and pharmacovigilance services, supporting communication with European authorities and safety reporting activities.

Pharmacovigilance for Clinical Trials

During clinical development, pharmacovigilance helps sponsors monitor the safety of investigational products.

Key activities may include:

• SAE and AE management
• ICSR processing
• Medical coding
• Safety database management
• SUSAR preparation and reporting
• Safety data reconciliation
• Investigator safety reporting support
• Literature monitoring

CurexBio specifically provides pharmacovigilance support for clinical trials, including safety database management, case processing, medical coding, safety reporting, and literature review.

Pharmacovigilance for Post-Marketing Studies

Safety monitoring continues after a product reaches the market. Post-marketing pharmacovigilance helps organizations evaluate safety information from broader patient populations and ongoing real-world use.

Services can include:

• Post-marketing safety surveillance
• ICSR management
• Signal detection
• Literature monitoring
• Aggregate reporting
• Risk management
• Safety data evaluation

CurexBio provides pharmacovigilance support from clinical development through post-marketing surveillance.

PV Audits, Training & Inspection Readiness

A robust pharmacovigilance system also requires appropriate procedures, training, oversight, and continuous quality monitoring.

CurexBio provides support for:

• PV system audits
• Internal audits
• Vendor and affiliate audits
• Mock inspections
• Inspection readiness
• SOP development and updates
• Pharmacovigilance training
• Regulatory updates

These services are designed to help organizations maintain operational and regulatory readiness.

Why Choose CurexBio for Pharmacovigilance Services in Sweden?

CurexBio combines pharmacovigilance expertise, safety technology, and regulatory knowledge to provide support across the drug safety lifecycle.

Its pharmacovigilance capabilities include:

ICSR Management → Medical Review → Safety Reporting → Literature Monitoring → Signal Detection → Risk Management → Safety Database Management → Regulatory Support

Conclusion

Effective pharmacovigilance requires continuous safety monitoring, accurate case processing, appropriate medical assessment, timely reporting, and proactive risk management.

With comprehensive Pharmacovigilance Services in Sweden, CurexBio supports organizations across clinical development and post-marketing stages through ICSR management, safety reporting, signal detection, literature monitoring, risk management, safety database support, and regulatory pharmacovigilance activities.

Looking for Pharmacovigilance Services in Sweden? Contact CurexBio Research to discuss your drug safety requirements.